The problem we figured out
Cancer is the second leading cause of death globally and is also becoming a major public health problem in Southeast Asia. Management of Cancer is primarily driven by either surgery or by drugs and/or radiation. However, approximately 80% of cancer patients do not survive more than 10 years. Cancer is a genomic disease, and every patient is unique and different. We need to have customized medicine for any given patient. Many of the current Cancer therapeutics are not customized. CAR-Ts has shown great success in a limited number of hematological Cancers but not in solid Cancers yet.
Our science and solution
We are developing personalized CAR-Ts to target both primary and metastasized Cancers based on our understanding of tumor microenvironments and antigen heterogeneity. CanFins will also develop an allogenic CAR-T platform to expedite personalized CAR-Ts for solid tumors.
Market growth and opportunity
The Global Cancer therapeutic market is ~ USD 150 Billion and is expected to be more than USD 400B by 2027.
Contact for further details:
Amjad Husain Ph.D., MBA,
+91 8861410623
amjad.husain@canfinis.com
Key Facts
|
||||
|---|---|---|---|---|
| Corporation | CanFinis Therapeutics Pvt Ltd | |||
| Founded on July 30th, 2021; Headquartered in Kolkata, India | ||||
| Traction | Collaborated with world class academic labs and government hospitals in India. | |||
| In licensing from US based Pharma/Biotechs | ||||
| Provisional patents (working progress) | ||||
| Area and market size | CAR-T cell therapy in Cancer | |||
| >$15B USD | ||||
| Valuation | Estimated $10M USD | |||
| Investment | Not needed now | |||
| Next milestone in 24 months | Setting up GMP and clinical labs | |||
| Engaging with clinical centers | ||||
| Streamline the regulatory path | ||||
| Initiation of Clinical POC study | ||||
| Founders and key leaders | Amjad Husain, PhD, MBA (CEO & Co-Founder) | |||
| Chandra Ghosh, PhD (Scientific Advisor & Co-Founder) | ||||
| Dr.Manas K Mondal, MD, DM (Co-Founder & CMO) | ||||
| Dr. Pinaki Roy, MD, DM (Co-Founder & Advisor) | ||||
| Pradip K. Majumder, PhD (Co-founder & Advisor) | ||||
| Dr. Badol Shaw, MD (Co-Founder and Advisor) | ||||